Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells

Liposomal doxorubicin (L-DOX) is a popular drug formulation for the treatment of several cancer types (e.g., recurrent ovarian cancer, metastatic breast cancer, multiple myeloma, etc.), but poor nuclear internalization has hampered its clinical applicability so far. Therefore, novel drug-delivery na...

Descripción completa

Detalles Bibliográficos
Autores principales: Quagliarini, Erica, Di Santo, Riccardo, Pozzi, Daniela, Tentori, Paolo, Cardarelli, Francesco, Caracciolo, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466571/
https://www.ncbi.nlm.nih.gov/pubmed/32751061
http://dx.doi.org/10.3390/nano10081482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466571/
https://www.ncbi.nlm.nih.gov/pubmed/32751061
http://dx.doi.org/10.3390/nano10081482

Ejemplares similares